Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scale

Abstract Background Globally, acute ischemic stroke (AIS) persists as a significant driver of both mortality and prolonged disability. Reliable biomarkers for predicting stroke outcomes must be identified to improve clinical decision-making. Residual cholesterol (RC) and RC inflammatory index (RCII)...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanmei Yu, Yiming Zhang, Chunyan Zhu, Tingting Duan, Zichen Rao
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Lipids in Health and Disease
Subjects:
Online Access:https://doi.org/10.1186/s12944-025-02650-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849767289467961344
author Yanmei Yu
Yiming Zhang
Chunyan Zhu
Tingting Duan
Zichen Rao
author_facet Yanmei Yu
Yiming Zhang
Chunyan Zhu
Tingting Duan
Zichen Rao
author_sort Yanmei Yu
collection DOAJ
description Abstract Background Globally, acute ischemic stroke (AIS) persists as a significant driver of both mortality and prolonged disability. Reliable biomarkers for predicting stroke outcomes must be identified to improve clinical decision-making. Residual cholesterol (RC) and RC inflammatory index (RCII) have been proposed as potential biomarkers, although their precise prognostic significance in stroke remains unclear. This research sought to examine the predictive value of RCII and RC in estimating extent of neurological impairment, assessed using the National Institutes of Health Stroke Scale (NIHSS), and functional recovery, evaluated using the three-month modified Rankin Scale (mRS), among individuals diagnosed with AIS. Methods The study enrolled 775 individuals diagnosed with AIS. RC and RCII were derived and subsequently grouped into quartiles for analysis. The associations between RCII, RC, NIHSS, and the three-month mRS were investigated using multivariable logistic regression analysis. Subpopulation analysis, inflection point analysis, generalized additive models (GAM), and receiver operating curve (ROC) analyses were utilized to evaluate the ability of these biomarkers to predict outcomes and to identify their optimal cutoff points. Results RCII demonstrated a significant relationship with unfavorable functional prognosis, with participants belonging to the top quartile of RCII levels having almost double the risk of poor outcomes compared to those in the lowest quartile. (odds ratio [OR] = 1.98, 95% confidence interval [CI]; 1.20–3.26, P = 0.0071). RC showed no significant association with the NIHSS or three-month mRS (P > 0.05). ROC analysis demonstrated that the RCII exhibited moderate discriminatory power in predicting poor three-month outcomes (AUC = 0.641, 95% CI; 0.595–0.688), whereas RC demonstrated modest predictive performance (AUC = 0.519, 95% CI; 0.475–0.564, P = 0.0018). GAM analysis revealed a J-shaped relationship for RCII, with optimal thresholds of 2.47 for NIHSS and 0.45 for three-month mRS, indicating significant associations above these cutoffs. The subgroup analysis showed stronger associations for RCII in men, smokers, and individuals with hypertension, but no significant associations were found for RC in any subgroup. Conclusion The RCII serves as an independent predictor of unfavorable three-month prognoses among individuals diagnosed with AIS. As a composite biomarker combining lipid and inflammatory factors, the RCII can enhance early risk stratification and guide personalized prognostic prediction in Acute stroke management.
format Article
id doaj-art-894986b2a41b4c9f8d445d0ae2e96ded
institution DOAJ
issn 1476-511X
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj-art-894986b2a41b4c9f8d445d0ae2e96ded2025-08-20T03:04:15ZengBMCLipids in Health and Disease1476-511X2025-07-0124111310.1186/s12944-025-02650-2Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scaleYanmei Yu0Yiming Zhang1Chunyan Zhu2Tingting Duan3Zichen Rao4Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou Medical CollegeDepartment of Endocrinology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s HospitalDepartment of Endocrinology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s HospitalDepartment of Neurology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s HospitalDepartment of Endocrinology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People’s HospitalAbstract Background Globally, acute ischemic stroke (AIS) persists as a significant driver of both mortality and prolonged disability. Reliable biomarkers for predicting stroke outcomes must be identified to improve clinical decision-making. Residual cholesterol (RC) and RC inflammatory index (RCII) have been proposed as potential biomarkers, although their precise prognostic significance in stroke remains unclear. This research sought to examine the predictive value of RCII and RC in estimating extent of neurological impairment, assessed using the National Institutes of Health Stroke Scale (NIHSS), and functional recovery, evaluated using the three-month modified Rankin Scale (mRS), among individuals diagnosed with AIS. Methods The study enrolled 775 individuals diagnosed with AIS. RC and RCII were derived and subsequently grouped into quartiles for analysis. The associations between RCII, RC, NIHSS, and the three-month mRS were investigated using multivariable logistic regression analysis. Subpopulation analysis, inflection point analysis, generalized additive models (GAM), and receiver operating curve (ROC) analyses were utilized to evaluate the ability of these biomarkers to predict outcomes and to identify their optimal cutoff points. Results RCII demonstrated a significant relationship with unfavorable functional prognosis, with participants belonging to the top quartile of RCII levels having almost double the risk of poor outcomes compared to those in the lowest quartile. (odds ratio [OR] = 1.98, 95% confidence interval [CI]; 1.20–3.26, P = 0.0071). RC showed no significant association with the NIHSS or three-month mRS (P > 0.05). ROC analysis demonstrated that the RCII exhibited moderate discriminatory power in predicting poor three-month outcomes (AUC = 0.641, 95% CI; 0.595–0.688), whereas RC demonstrated modest predictive performance (AUC = 0.519, 95% CI; 0.475–0.564, P = 0.0018). GAM analysis revealed a J-shaped relationship for RCII, with optimal thresholds of 2.47 for NIHSS and 0.45 for three-month mRS, indicating significant associations above these cutoffs. The subgroup analysis showed stronger associations for RCII in men, smokers, and individuals with hypertension, but no significant associations were found for RC in any subgroup. Conclusion The RCII serves as an independent predictor of unfavorable three-month prognoses among individuals diagnosed with AIS. As a composite biomarker combining lipid and inflammatory factors, the RCII can enhance early risk stratification and guide personalized prognostic prediction in Acute stroke management.https://doi.org/10.1186/s12944-025-02650-2Remnant cholesterolIschemic strokeC-reactive proteinModified Rankin scaleInflammation mediators
spellingShingle Yanmei Yu
Yiming Zhang
Chunyan Zhu
Tingting Duan
Zichen Rao
Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scale
Lipids in Health and Disease
Remnant cholesterol
Ischemic stroke
C-reactive protein
Modified Rankin scale
Inflammation mediators
title Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scale
title_full Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scale
title_fullStr Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scale
title_full_unstemmed Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scale
title_short Remnant cholesterol inflammatory index, calculated from residual cholesterol to C-reactive protein ratio, and stroke outcomes: a retrospective study using the National institutes of health stroke scale and modified Rankin scale
title_sort remnant cholesterol inflammatory index calculated from residual cholesterol to c reactive protein ratio and stroke outcomes a retrospective study using the national institutes of health stroke scale and modified rankin scale
topic Remnant cholesterol
Ischemic stroke
C-reactive protein
Modified Rankin scale
Inflammation mediators
url https://doi.org/10.1186/s12944-025-02650-2
work_keys_str_mv AT yanmeiyu remnantcholesterolinflammatoryindexcalculatedfromresidualcholesteroltocreactiveproteinratioandstrokeoutcomesaretrospectivestudyusingthenationalinstitutesofhealthstrokescaleandmodifiedrankinscale
AT yimingzhang remnantcholesterolinflammatoryindexcalculatedfromresidualcholesteroltocreactiveproteinratioandstrokeoutcomesaretrospectivestudyusingthenationalinstitutesofhealthstrokescaleandmodifiedrankinscale
AT chunyanzhu remnantcholesterolinflammatoryindexcalculatedfromresidualcholesteroltocreactiveproteinratioandstrokeoutcomesaretrospectivestudyusingthenationalinstitutesofhealthstrokescaleandmodifiedrankinscale
AT tingtingduan remnantcholesterolinflammatoryindexcalculatedfromresidualcholesteroltocreactiveproteinratioandstrokeoutcomesaretrospectivestudyusingthenationalinstitutesofhealthstrokescaleandmodifiedrankinscale
AT zichenrao remnantcholesterolinflammatoryindexcalculatedfromresidualcholesteroltocreactiveproteinratioandstrokeoutcomesaretrospectivestudyusingthenationalinstitutesofhealthstrokescaleandmodifiedrankinscale